Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Qualigen Therapeutics Inc
QLGNCurrent price
3.24 USD
+0.01 USD (+0.31%)
Last closed
3.14 USD
Company
www.qualigeninc.com
ISIN
US74754R1032
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 422 859 USD
Yield for 12 month
-78.06 %
1Y
3Y
5Y
10Y
15Y
QLGN
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. Address: 5857 Owens Avenue, Carlsbad, CA, United States, 92008
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.00 USDP/E ratio
0.00090Dividend Yield
–Current Year
+5 204 755 USD
Last Year
+4 983 556 USD
Current Quarter
–
Last Quarter
–
Current Year
-4 495 USD
Last Year
+680 801 USD
Current Quarter
–
Last Quarter
-754 287 USD
Key Figures QLGN
1 year
3 years
5 years
10 years
EBITDA
-6 886 340 USD
Operating Margin TTM
Price to Earnings
0.00090
Return On Assets TTM
-126.39 %
PEG Ratio
–
Return On Equity TTM
-841.66 %
Wall Street Target Price
5.00 USD
Revenue TTM
4 983 556 USD
Book Value
-3.91 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
13.70 %
Dividend Yield
–
Gross Profit TTM
-2 553 290 USD
Earnings per share
3 579.76 USD
Diluted Eps TTM
3 579.76 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics QLGN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History QLGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
05.11.2024
Stock Valuation QLGN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.00090
Forward PE
–
Enterprise Value Revenue
0.68
Price Sales TTM
0.39
Enterprise Value EBITDA
-0.054
Price Book MRQ
0.41
Financials QLGN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators QLGN
For 52 weeks
2.85 USD
29.44 USD
50 Day MA
3.27 USD
Shares Short Prior Month
70 049
200 Day MA
6.37 USD
Short Ratio
2.00
Shares Short
119 498
Short Percent
16.24 %
BeatStart